LivaNova Newsroom

Needham Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $75

Futu NewsNov 25 19:33

Barclays Maintains LivaNova(LIVN.US) With Hold Rating, Maintains Target Price $61

Futu NewsNov 13 18:31

Barclays Releases a Hold Rating on LivaNova (LIVN)

TipRanksNov 13 18:14

Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating

Futu NewsNov 13 16:31

LivaNova Analyst Ratings

BenzingaNov 12 23:58

Needham Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $75

Futu NewsNov 12 21:31

A Quick Look at Today's Ratings for LivaNova(LIVN.US), With a Forecast Between $70 to $75

Futu NewsNov 1 21:19

LivaNova Is Maintained at Outperform by Mizuho

Dow JonesOct 31 22:41

Baird Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $72

Futu NewsOct 31 19:37

Piper Sandler Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $75

Futu NewsOct 31 19:34

LivaNova Analyst Ratings

BenzingaOct 31 18:14

Needham Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $75

Futu NewsOct 31 04:31

LivaNova Analyst Ratings

BenzingaOct 4 19:44

Goldman Sachs Initiates LivaNova(LIVN.US) With Buy Rating, Announces Target Price $65

Futu NewsOct 4 16:33

Analysts Conflicted on These Healthcare Names: LivaNova (LIVN), Johnson & Johnson (JNJ) and Avidity Biosciences (RNA)

TipRanksOct 4 16:32

Baird Upgrades LivaNova(LIVN.US) to Buy Rating, Raises Target Price to $66

Futu NewsSep 17 17:33

LivaNova: Strong Buy Rating on Robust Revenue and Earnings Growth Outlook

TipRanksSep 17 16:59

Barclays Maintains LivaNova(LIVN.US) With Hold Rating, Maintains Target Price $61

Futu NewsAug 30 16:32

LivaNova (LIVN) Gets a Hold From Barclays

TipRanksAug 30 16:17

Baird Maintains Neutral on LivaNova, Maintains $55 Price Target

BenzingaAug 29 01:43